Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancer Monica ArnedosStephanie SutherlandIan Smith Review 01 December 2007 Pages: 1 - 4
How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature O. MintonP. Stone Review 07 December 2007 Pages: 5 - 13
In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients Barbara E. LicznerskaPia P. WegmanSten Wingren Preclinical Study 20 November 2007 Pages: 15 - 23
Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling Nicola NormannoManuela CampiglioSylvie Menard Preclinical Study 30 November 2007 Pages: 25 - 33
The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women James G. DowtyFelicity LoseAmanda B. Spurdle Preclinical Study 04 December 2007 Pages: 35 - 39
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer Eugen RuckhäberleAchim RodyManfred Kaufmann Preclinical Study 04 December 2007 Pages: 41 - 52
Inactivation of NF-κB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells Josep Domingo-DomènechRaffaella PippaMarta Bosch Preclinical Study 06 December 2007 Pages: 53 - 62
Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family Sarai Palanca SuelaEva Esteban Cardeñosaon behalf of the Group for Assessment of Hereditary Cancer of Valencia Community Preclinical Study 01 December 2007 Pages: 63 - 67
Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain Eva Esteban CardeñosaPascual Bolufer Gilaberton behalf of the Group for Assessment of Hereditary Cancer of Valencia Community Epidemiology 01 December 2007 Pages: 69 - 73
NBS1 variant I171V and breast cancer risk Natalia BogdanovaPeter SchürmannThilo Dörk Epidemiology 30 November 2007 Pages: 75 - 79
TGFβ1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFβ1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy Thangarajan RajkumarMani SamsonNirmala K. Nancy Epidemiology 05 December 2007 Pages: 81 - 87
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients Peter Andreas FaschingChristian R. LoehbergReiner Strick Epidemiology 30 November 2007 Pages: 89 - 98
Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer Wilhelmina E. HoogendoornHarry HollemaThe Comprehensive Cancer Centers’ TAMARISK-group Epidemiology 07 December 2007 Pages: 99 - 108
Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density Martijn VerheusJames D. McKayCarla H. van Gils Epidemiology 07 December 2007 Pages: 109 - 122
Breast cancer recurrence risk in relation to antidepressant use after diagnosis Jessica ChubakDiana S. M. BuistNoel S. Weiss Epidemiology 06 December 2007 Pages: 123 - 132
Nonsteroidal anti-inflammatory drugs (NSAIDs) and mammographic density Gertraud MaskarinecYasuko UranoLaurence N. Kolonel Epidemiology 29 November 2007 Pages: 133 - 139
Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients An-Chi LoCelina G. KleerAmr S. Soliman Epidemiology 04 December 2007 Pages: 141 - 147
Dietary fiber is associated with serum sex hormones and insulin-related peptides in postmenopausal breast cancer survivors Sharon J. WayneMarian L. NeuhouserRachel Ballard-Barbash Epidemiology 05 December 2007 Pages: 149 - 158
Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations Zdenek KleiblOndrej HavranekPetr Pohlreich Epidemiology 04 December 2007 Pages: 159 - 164
Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN) Lesley M. ButlerEllen B. GoldLaurel A. Habel Epidemiology 09 December 2007 Pages: 165 - 174
Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan Masahide KondoShu Ling HoshiMasakazu Toi Epidemiology 13 December 2007 Pages: 175 - 187
Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy Eunyoung KoWonshik HanDong-Young Noh Clinical Trial 04 December 2007 Pages: 189 - 195
Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy Rudolph M. NavariMarie C. BrennerMegan N. Wilson Clinical Trial 07 December 2007 Pages: 197 - 201
Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17) Brigitte MlineritschChristoph Tauschon behalf of the Austrian Breast, Colorectal Cancer Study Group (ABCSG) Clinical Trial 22 December 2007 Pages: 203 - 213
Prognostic factors in long-term breast cancer survivors with brain metastases Hakan HarputluogluAtilla KaraKadri Altundag Letter to the Editor 04 December 2007 Pages: 215 - 215
